Insider Transactions in Q1 2021 at Acadia Pharmaceuticals Inc (ACAD)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 04
2021
|
Austin D. Kim EVP,General Counsel, Secretary |
SELL
Open market or private sale
|
Direct |
2,107
-17.53%
|
$105,350
$50.61 P/Share
|
|
Feb 04
2021
|
Austin D. Kim EVP,General Counsel, Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
6,009
+33.33%
|
-
|
|
Feb 04
2021
|
Srdjan R. Stankovic President |
SELL
Open market or private sale
|
Direct |
8,429
-21.35%
|
$421,450
$50.61 P/Share
|
|
Feb 04
2021
|
Srdjan R. Stankovic President |
BUY
Grant, award, or other acquisition
|
Direct |
19,231
+32.76%
|
-
|
|
Feb 04
2021
|
Stephen Davis CEO |
SELL
Open market or private sale
|
Direct |
14,195
-32.94%
|
$709,750
$50.61 P/Share
|
|
Feb 04
2021
|
Stephen Davis CEO |
BUY
Grant, award, or other acquisition
|
Direct |
31,250
+42.05%
|
-
|
|
Feb 04
2021
|
Elena Ridloff EVP and CFO |
SELL
Open market or private sale
|
Direct |
2,051
-19.74%
|
$102,550
$50.61 P/Share
|
|
Feb 04
2021
|
Elena Ridloff EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
6,490
+38.45%
|
-
|
|
Jan 12
2021
|
Srdjan R. Stankovic President |
SELL
Open market or private sale
|
Direct |
700
-3.34%
|
$38,500
$55.01 P/Share
|
|
Jan 12
2021
|
Srdjan R. Stankovic President |
BUY
Exercise of conversion of derivative security
|
Direct |
700
+3.23%
|
$12,600
$18.12 P/Share
|
|
Jan 08
2021
|
Srdjan R. Stankovic President |
SELL
Open market or private sale
|
Direct |
29,733
-59.49%
|
$1,635,315
$55.22 P/Share
|
|
Jan 08
2021
|
Srdjan R. Stankovic President |
BUY
Exercise of conversion of derivative security
|
Direct |
29,733
+18.89%
|
$743,325
$25.07 P/Share
|
|
Jan 07
2021
|
Srdjan R. Stankovic President |
SELL
Open market or private sale
|
Direct |
61,619
-75.27%
|
$3,389,045
$55.12 P/Share
|
|
Jan 07
2021
|
Srdjan R. Stankovic President |
BUY
Exercise of conversion of derivative security
|
Direct |
61,619
+42.94%
|
$2,156,665
$35.8 P/Share
|
|
Jan 06
2021
|
Stephen Davis CEO |
SELL
Open market or private sale
|
Direct |
3,484
-12.46%
|
$184,652
$53.34 P/Share
|
|
Jan 06
2021
|
Stephen Davis CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,527
+25.41%
|
-
|
|
Jan 06
2021
|
Srdjan R. Stankovic President |
SELL
Open market or private sale
|
Direct |
1,725
-7.85%
|
$91,425
$53.34 P/Share
|
|
Jan 06
2021
|
Srdjan R. Stankovic President |
BUY
Exercise of conversion of derivative security
|
Direct |
5,444
+19.86%
|
-
|
|
Jan 06
2021
|
Elena Ridloff EVP and CFO |
SELL
Open market or private sale
|
Direct |
1,016
-20.66%
|
$53,848
$53.34 P/Share
|
|
Jan 06
2021
|
Elena Ridloff EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,722
+35.63%
|
-
|
|
Jan 06
2021
|
Austin D. Kim EVP,General Counsel, Secretary |
SELL
Open market or private sale
|
Direct |
678
-10.94%
|
$35,934
$53.34 P/Share
|
|
Jan 06
2021
|
Austin D. Kim EVP,General Counsel, Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
1,633
+20.86%
|
-
|
|
Jan 06
2021
|
Michael J. Yang EVP and CCO |
SELL
Open market or private sale
|
Direct |
1,120
-12.2%
|
$59,360
$53.34 P/Share
|
|
Jan 06
2021
|
Michael J. Yang EVP and CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,722
+22.87%
|
-
|